السبت 6 جمادى الأولى 1448هـ
جميع روابط المواقع الرسمية التابعة للجهات الحكومية في المملكة العربية السعودية تنتهي بـ .gov.sa
تحقق من أن الموقع يستخدم بروتوكول HTTPS
مسجل لدى هيئة الحكومة الرقمية برقم :
| عنوان الدراسة | داعم الدراسة | حالة الدراسة | دواء الدراسة | مرحلة الدراسة | رقم بروتوكول الدراسة | موقع الدراسة |
|---|---|---|---|---|---|---|
| "A Phase 3, Randomized, Double-Blinded, Double-Dummy Study Evaluating the Efficacy and Safety of Intravenous Empasiprubart Versus Intravenous Immunoglobulin in Adults with Chronic Inflammatory Demyelinating Polyneuropathy" | Argenx BV/ Balsam | Ongoing | Empasiprubart (ARGX-117) | 3 | ARGX-117-2401 | King Faisal Specialist Hospital and Research Center (Riyadh) |
| A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Participants with Moderately to Severely Active Systemic Lupus Erythematosus | UCB Biopharma SRL/ PDC | Ongoing | Dapirolizumab (BIIB133) | 3 | SL0044 | King Fahad Medical City (Riyadh) |
| A Phase III Randomized, Double-blind, Placebo-controlled Multicenter Master Protocol to Evaluate the Efficacy and Safety of Elecoglipron in Participants with Obesity or Overweight with or without Type 2 Diabetes Mellitus (Embold) | Astrazeneca UK Ltd. | Ongoing | Elecoglipron | 3 | D7260C00015 | King Fahad Specialist Hospital (Dammam) |
| Levofloxacin Versus Rifabutin Based Triple Therapy as A Salvage Treatment for Helicobacter Pylori Eradication: Prospective Randomized Trial | King Faisal Specialist Hospital and Research Center (Riyadh) | Ongoing | Levofloxacin / Rifabutin | 3 | 2251618 | King Faisal Specialist Hospital and Research Center (Riyadh) |
| A Phase 1/2/3 Study to Evaluate the Safety, Tolerability, and Efficacy of VX-880 in Subjects Who Have Type 1 Diabetes Mellitus With Impaired Hypoglycemic Awareness and Severe Hypoglycemia | Vertex / CTI | Ongoing | VX 880 | 3 | VX20-880-101 | King Abdulaziz Hospital NG (Riyadh) |
| Evaluation of safety and efficacy of non-anesthesia provider-administered different anesthetic regimens during colonoscopy: a single center, prospective double blind, randomized study | PI initiated | Ongoing | Propofol | 4 | 6074515 | King Saud Hospital (Unaizah) |
| A global phase 3, randomised, double-blind and placebo-controlled study evaluating the efficacy and safety of etavopivat in adolescents and adults with sickle cell disease | Novo Nordisk | Ongoing | Etavopivat | 3 | NN7535-7807 | 1.King Faisal Specialist Hospital and Researech Center - Riyadh 2. National Guard Health Affairs - Alahsa 3.Imam Abdulrahman Bin Faisal University - Dammam 4. King Saud University Medical city - Riyadh 5.Prince Mohammed bin Fahad hospital- Qatif |
| Registry-based study of patients treated with exagamglogene autotemcel (exa-cel) in the Kingdom of Saudi Arabia | Vertex | Ongoing | Exagamglogene autotemcel (Casgevy) | 4 | 290-103 | - |
| A Phase II/III, Extension Study of Orally Administered PHA-022121 for Acute Treatment of Angioedema Attacks in Patients with Hereditary Angioedema due to C1-Inhibitor Deficiency (Type I or Type II (RAPIDe-2) | Pharvaris Netherlands B.V. | Ongoing | Deucrictibant | 2/3 | PHA022121-C303 | King Faisal Specialist Hospital and Research Center (Riyadh) |
| Patient and prescriber survey: effectiveness measures to investigate awareness, knowledge, and adherence to the additional risk minimisation measures (aRMM) of the patient reminder card for oral ambrisentan (PrVolibris®) | GSK | Ongoing | Ambrisentan | 4 | 221772 | King Abdullah International Medical Research Center– Jeddah |
تاريخ آخر تحديث: 06/10/2026 بتمام الساعة 08:14 صباحا بتوقيت المملكة العربية السعودية
لم يتم تقديم أي تقييمات لهذه الصفحة بعد.
التعليقات والاقتراحات
لأي استفسارات أو ملاحظات حول الخدمات الحكومية، يرجى تعبئة المعلومات المطلوبة.